Premium
TREATMENT OF BASAL CELL CARCINOMA OF THE EYELID
Author(s) -
NORDMAN E. M.,
NORDMAN L. E. O.
Publication year - 1978
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1978.tb05687.x
Subject(s) - eyelid , basal cell carcinoma , medicine , radiation therapy , basal cell , surgery , carcinoma , basal (medicine) , surgical excision , insulin
109 cases treated for basal cell carcinoma of the lid are presented. Of the 79 patients who received radiation treatment alone, 65 (82%) were recurrence‐free at two years and of the 45 followed for five years, 31 (69%) were recurrence‐free. Of the 30 cases radically excised, 27 (90%) were cured at two years, and all of the 15 who were followed for five years. Small tumours were cured as effectively with irradiation (98%) as with excision (92%). Larger tumours with a diameter of more than one cm seemed to have a less favourable result with radiotherapy, 20/33 for two years and 9/21 for five years, than with excision, 6/7 and 5/5, respectively.